Gainers
- Synthorx, Inc. THOR shares climbed 169.1% to $67.36 after the company announced it would be acquired by Sanofi for $68 per share in cash.
- ArQule, Inc. ARQL shares rose 103.5% to $19.67 after the company agreed to be acquired by Merck & Co., Inc. MRK for $20 per share in cash.
- XBiotech Inc. XBIT shares gained 85.5% to $20.63 after the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.
- Forty Seven, Inc. FTSV shares rose 65% to $23.83 after the company announced data for its Magrolimab trial showing a complete response rate of 50% and an overall response rate of 92% observed in untreated patients with risk in Myelodysplastic syndrome.
- Fate Therapeutics, Inc. FATE shares gained 42.6% to $19.50 after the company announced positive preliminary data from its FT596 study and Wells Fargo upgraded its rating of the stock to Outperform.
- Neoleukin Therapeutics, Inc. NLTX jumped 32.8% to $5.39.
- Aptose Biosciences Inc. APTO rose 30.5% to $3.34.
- Constellation Pharmaceuticals, Inc. CNST gained 28.3% to $56.07 after the company offered updated preliminary data from MANIFEST trial with CPI-0610 in oral and poster presentations at the ASH.
- TG Therapeutics, Inc. TGTX surged 27.8% to $9.10 after the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.
- PDL BioPharma Inc PDLI jumped 23.1% to $3.63 after the company announced the completion of its strategic review. It will halt the execution of its growth strategy and focus on returning proceeds from asset sales to shareholders. The company also announced a $200 million buyback.
- LMP Automotive Holdings Inc LMPX gained 19.8% to $6.89.
- BioNTech SE BNTX gained 18% to $28.74.
- Stage Stores, Inc. SSI shares rose 17.7% to $6.65.
- PG&E Corporation PCG gained 17.2% to $11.31 after the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.
- Antero Resources Corp AR gained 16.4% to $2.55 after Antero Midstream announced a $100 million buyback of the company's stock.
- Advaxis, Inc. ADXS gained 15% to $0.88.
- LiveXLive Media, Inc. LIVX rose 13.9% to $2.62
- Aprea Therapeutics, Inc. APRE rose 13.7% to $29.62.
- IVERIC bio, Inc. ISEE gained 13% to $4.97.
- Virgin Galactic Holdings Inc SPCE jumped 12.7% to $8.18 after Morgan Stanley initiated coverage on the stock with an Overweight rating and a price target of $22 per share.
- OptimizeRx Corporation OPRX rose 12.6% to $10.18. OptimizeRx said its sales pipeline has increased 79% in 2019 to $84 million.
- Canopy Growth Corporation CGC shares gained 12% to $20.89 after the company announced David Klein as the new CEO.
- Greenlane Holdings, Inc. GNLN shares jumped 11.6% to $2.9789.
- Repro Med Systems, Inc. KRMD shares rose 10.8% to $5.45.
- Dermira, Inc. DERM gained 10.5% to $8.71.
- Minerva Neurosciences, Inc. NERV shares jumped 10.4% to $6.90.
- comScore, Inc. SCOR shares gained 9.9% to $4.65.
- Antero Midstream Corporation AM shares jumped 9.6% to $4.92 after the company announced it will buy back $100 million shares from Antero Resources.
- X4 Pharmaceuticals, Inc. XFOR shares rose 9.5% to $11.72. Citigroup upgraded X4 Pharmaceuticals from Neutral to Buy.
- Akerna Corp. KERN shares surged 9.4% to $11.36.
- Turning Point Therapeutics, Inc. TPTX gained 9.3% to $56.01.
- LG Display Co., Ltd. LPL rose 9.1% to $6.80.
- TransMedics Group, Inc. TMDX shares gained 8.6% to $20.67.
Check out these big penny stock gainers and losers
Losers
- Biocept Inc BIOC shares tumbled 49.3% to $0.2736 after the company priced 24.6 million unit offering at $0.405 per unit.
- Precision BioSciences, Inc. DTIL dropped 41.1% to $11.59 after the company reported updated interim clinical data from the ongoing Phase 1 trial of its lead investigational off-the-shelf (allogeneic) chimeric antigen receptor (CAR) T cell therapy candidate, PBCAR019.
- Diplomat Pharmacy, Inc. DPLO fell 31.8% to $3.96 after the company received a $4 per share acquisition offer from United Health's OptumRx..
- Kosmos Energy Ltd. KOS fell 21.4% to $4.7450.
- Mustang Bio, Inc. MBIO shares declined 10.7% to $3.44.
- Celldex Therapeutics, Inc. CLDX shares fell 9.5% to $2.29.
- Garrett Motion Inc. GTX shares declined 9.5% to $10.51.
- Onconova Therapeutics Inc ONTX dipped 9.5% to $0.3169 after the company announced data from INSPIRE related abstracts at the American Society of Hematology 2019 Annual Meeting.
- Endo International plc ENDP shares fell 9.2% to $4.3950.
- Brigham Minerals, Inc. MNRL shares dropped 8.8% to $17.96 after the company reported an 11 million share stock offering.
- Proteostasis Therapeutics, Inc. PTI shares declined 8.5% to $3.25.
- Liquid Media Group Ltd. YVR fell 8.3% to $2.23.
- Endologix, Inc. ELGX shares dropped 7.9% to $2.1750.
- Global Blood Therapeutics, Inc. GBT dipped 7.4% to $73.51.
- Galmed Pharmaceuticals Ltd. GLMD shares tumbled 7.1% to $6.04.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in